SCHEMBL8058591

SCHEMBL8058591

O=C(O)C(CCC1CCCCC1)(c1ccccc1)[PH](=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CCR1 P32246 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EPHX1 P07099 1/20 0.38
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CHRM2 P08172 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059141 0.80 HPGD (0.43) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL8059152 0.76 HPGD (0.41) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL8058466 0.75 HPGD (0.41) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL7633968 0.73 KIF11 (0.43) ALDH1A1KMT2ATDP1NPC1RAB9A
SCHEMBL8058503 0.72 HPGD (0.46) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL7639980 0.72 GAA (0.41) ALDH1A1NPC1RAB9AKIF11
SCHEMBL6270462 0.72 CHRM2 (0.45) EPHX2KEAP1NFE2L2MEN1KMT2A
SCHEMBL7644315 0.71 GRM2 (0.44) TDP1NPC1RAB9ASMN1; SMN2
SCHEMBL3999140 0.70 KEAP1 (0.43) EPHX2KEAP1NFE2L2ALDH1A1MEN1
SCHEMBL8059180 0.69 GRM2 (0.45) CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6046180-A NAALADase inhibitors GUILFORD PHARMACEUTICALS INC. (US) 2000-04-04 US claimed